Related Experiment Video
Updated: Aug 4, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
The serum digoxin test and digoxin toxicity: a Bayesian approach to decision making
Circulation
|August 1, 1981
Summary
The serum digoxin test aids clinicians in diagnosing digoxin toxicity, especially when deciding whether to continue or stop the medication. This method clarifies the test
Area of Science:
- Clinical Pharmacology
- Toxicology
- Medical Decision Making
Background:
- Clinicians often face uncertainty regarding digoxin toxicity.
- This uncertainty complicates critical therapeutic decisions about digoxin use.
Purpose of the Study:
- To describe a method for clarifying the role of serum digoxin testing in diagnosing and treating digoxin toxicity.
- To develop an approach for interpreting serum digoxin test results based on likelihood ratios and pretest risk.
Main Methods:
- Determined the relationship between serum digoxin levels and toxicity in a patient population.
- Combined patient data with literature data to develop a likelihood ratio-based interpretation method.
- Established the relationship between pretest risk and the predictive value of the serum digoxin test.
Main Results:
- The serum digoxin test was found to influence therapeutic decisions by altering the probability of toxicity.
- The degree of elevation in serum digoxin levels was analyzed for its impact on predictive value.
- An intermediate range of pretest risk was identified where the test effectively shifted the probability of toxicity across the treatment threshold.
Conclusions:
- The serum digoxin test plays a critical role in therapeutic decision-making for potential digoxin toxicity.
- The test's utility is best understood as contributing to a spectrum of risk assessment.
- This approach helps reduce diagnostic uncertainty, guiding appropriate treatment initiation.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...